StockNews.com initiated coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a research note published on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Other research analysts have also issued reports about the company. HC Wainwright reaffirmed a buy rating and issued a $9.00 price objective on shares […]